RNA polymerase beta subunit — Drug Target

All drugs that target RNA polymerase beta subunit — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Antibiotic · Antitubercular

Phase 3 pipeline (2)

• double-blind rifaximin · Bausch Health Americas, Inc. · Antibiotic · Gastroenterology
  Rifaximin works by inhibiting bacterial RNA synthesis.
• RIFINAH © · Assistance Publique - Hôpitaux de Paris · Antitubercular · Infectious Diseases
  Rifinah is an antitubercular medication that works by inhibiting the synthesis of mycolic acid in Mycobacterium tuberculosis.